Journal article · 2009
Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making
Expert Opinion on Pharmacotherapy, 10(12), 1917–1928 · Published 28 June 2009 · DOI 10.1517/14656560903061309
In brief
“Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making” is a 2009 journal article by Jan Volavka and Leslie Citrome, published in Expert Opinion on Pharmacotherapy. OpenAlex counts 81 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 81
- Most cited in
- 2016 (8)
- Field-weighted impact
- 4.20
- References
- 89
- Authors
- 2
Abstract
BACKGROUND: Antipsychotic medications are conventionally divided into two groups: First-generation and second-generation antipsychotics (FGAs and SGAs). There is a disagreement about the role of these two groups in the treatment of schizophrenia. OBJECTIVE: To analyze the reasons for the disagreement and to propose a resolution that would improve the treatment of schizophrenia. METHOD: An overview… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Volavka, J., & Citrome, L. (2009). Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making. Expert Opinion on Pharmacotherapy, 10(12), 1917–1928. https://doi.org/10.1517/14656560903061309
MLA 9
Volavka, Jan, and Leslie Citrome. “Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.” Expert Opinion on Pharmacotherapy, vol. 10, no. 12, 2009, pp. 1917–1928. https://doi.org/10.1517/14656560903061309.
Chicago
Volavka, Jan and Leslie Citrome. 2009. “Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.” Expert Opinion on Pharmacotherapy 10 (12): 1917–1928. https://doi.org/10.1517/14656560903061309.
Harvard
Volavka, J. and Citrome, L. (2009) ‘Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making’, Expert Opinion on Pharmacotherapy, 10(12), pp. 1917–1928. doi:10.1517/14656560903061309.
IEEE
J. Volavka and L. Citrome, “Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making,” Expert Opinion on Pharmacotherapy, vol. 10, no. 12, pp. 1917–1928, 2009, doi: 10.1517/14656560903061309.
BibTeX
@article{volavka2009oral,
title = {{Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making}},
author = {Volavka, Jan and Citrome, Leslie},
journal = {Expert Opinion on Pharmacotherapy},
year = {2009},
volume = {10},
number = {12},
pages = {1917--1928},
doi = {10.1517/14656560903061309},
url = {https://doi.org/10.1517/14656560903061309}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2016 | 8 | |
| 2017 | 3 | |
| 2018 | 5 | |
| 2019 | 1 | |
| 2020 | 1 | |
| 2021 | 2 | |
| 2022 | 4 | |
| 2023 | 4 | |
| 2024 | 6 | |
| 2025 | 1 |
Its field-weighted citation impact is 4.20: it has been cited 4.20 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- schizophrenia
- antipsychotic drugs
- typical antipsychotics
- atypical antipsychotics
- antipsychotic efficacy
- antipsychotic tolerability
- extrapyramidal symptoms
- tardive dyskinesia
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Volavka, J., & Citrome, L. (2009). Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making. Expert Opinion on Pharmacotherapy, 10(12), 1917–1928. https://doi.org/10.1517/14656560903061309
How many times has this paper been cited?
81 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Jan Volavka, Leslie Citrome.
What is the DOI of this paper?
10.1517/14656560903061309, permanently at https://doi.org/10.1517/14656560903061309. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.